<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="8" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font1" size="8" family="AkzidenzGroteskBE-Md,Bold" color="#000000"/>
	<fontspec id="font2" size="8" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font3" size="7" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font4" size="9" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font5" size="9" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font6" size="9" family="SymbolMT" color="#000000"/>
	<fontspec id="font7" size="6" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font8" size="8" family="AkzidenzGroteskBE" color="#ffffff"/>
	<fontspec id="font9" size="8" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
<text top="42" left="315" width="241" height="7" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title">Available online http://breast-cancer-research.com/content/8/5/R56<b>Available online</b></text>
<text top="758" left="506" width="49" height="7" font="font2" id="p1_t2" reading_order_no="77" segment_no="6" tag_type="text">Page 11 of 15</text>
<text top="769" left="436" width="120" height="6" font="font3" id="p1_t3" reading_order_no="78" segment_no="7" tag_type="text">(page number not for citation purposes)</text>
<text top="320" left="57" width="240" height="9" font="font4" id="p1_t4" reading_order_no="5" segment_no="3" tag_type="text">malignant samples by normal or reactive stromal cells, as well<i>(page number not for citation purposes)</i></text>
<text top="332" left="57" width="240" height="9" font="font4" id="p1_t5" reading_order_no="6" segment_no="3" tag_type="text">as the induction of inflammatory genes due to in vitro manipu-</text>
<text top="344" left="57" width="240" height="9" font="font4" id="p1_t6" reading_order_no="7" segment_no="3" tag_type="text">lation, could result in false positives. However, verification of</text>
<text top="355" left="57" width="240" height="9" font="font4" id="p1_t7" reading_order_no="8" segment_no="3" tag_type="text">the probable epithelial origin of differentially expressed genes<i>in vitro </i></text>
<text top="367" left="57" width="240" height="9" font="font4" id="p1_t8" reading_order_no="9" segment_no="3" tag_type="text">can be obtained by comparing expression data from breast</text>
<text top="379" left="57" width="240" height="9" font="font4" id="p1_t9" reading_order_no="10" segment_no="3" tag_type="text">epithelial cell lines [22], breast tumour cell lines or, as in the</text>
<text top="391" left="57" width="240" height="9" font="font4" id="p1_t10" reading_order_no="11" segment_no="3" tag_type="text">present study, by immunohistochemistry, all of which show</text>
<text top="402" left="57" width="241" height="9" font="font4" id="p1_t11" reading_order_no="12" segment_no="3" tag_type="text">that, for example, IL8, is a bona fide epithelial tumour-associ-</text>
<text top="414" left="57" width="240" height="9" font="font4" id="p1_t12" reading_order_no="13" segment_no="3" tag_type="text">ated product [43,44]. One of the features of normal luminal<a href="">ll lines [22], breast tumou</a>r cell lines or, as in the</text>
<text top="426" left="57" width="240" height="9" font="font4" id="p1_t13" reading_order_no="14" segment_no="3" tag_type="text">epithelial cultures is the loss of estrogen receptor expression</text>
<text top="438" left="57" width="240" height="9" font="font4" id="p1_t14" reading_order_no="15" segment_no="3" tag_type="text">[45]. The microarray gene expression profiling currently used</text>
<text top="449" left="57" width="240" height="9" font="font4" id="p1_t15" reading_order_no="16" segment_no="3" tag_type="text">to classify breast cancers supports the paradigm that ER sta-<i>bona fide </i></text>
<text top="461" left="57" width="241" height="9" font="font4" id="p1_t16" reading_order_no="17" segment_no="3" tag_type="text">tus is the most important phenotype in breast cancer and has</text>
<text top="473" left="57" width="240" height="9" font="font4" id="p1_t17" reading_order_no="18" segment_no="3" tag_type="text">led to the classification of breast cancers into luminal A (ER-<a href="">ated product [43,44]. On</a>e of the features of normal luminal</text>
<text top="485" left="57" width="240" height="9" font="font4" id="p1_t18" reading_order_no="19" segment_no="3" tag_type="text">positive good prognosis) and luminal B (ER-positive poor</text>
<text top="496" left="57" width="240" height="9" font="font4" id="p1_t19" reading_order_no="20" segment_no="3" tag_type="text">prognosis), and ER-negative myoepithelial/basal and HER2<a href="">[45]. The</a> microarray gene expression profiling currently used</text>
<text top="508" left="57" width="240" height="9" font="font4" id="p1_t20" reading_order_no="21" segment_no="3" tag_type="text">subtypes, each with distinct differences in prognosis and</text>
<text top="520" left="57" width="240" height="9" font="font4" id="p1_t21" reading_order_no="22" segment_no="3" tag_type="text">response to therapy [4,5,46]. Genes identified in this study</text>
<text top="532" left="57" width="240" height="9" font="font4" id="p1_t22" reading_order_no="23" segment_no="3" tag_type="text">representing the normal luminal epithelial phenotype are dis-</text>
<text top="543" left="57" width="240" height="9" font="font4" id="p1_t23" reading_order_no="24" segment_no="3" tag_type="text">tinct from the subset of genes that are associated with ER</text>
<text top="555" left="57" width="240" height="9" font="font4" id="p1_t24" reading_order_no="25" segment_no="3" tag_type="text">expression and are used to classify 'luminal' breast tumours.</text>
<text top="567" left="57" width="240" height="9" font="font4" id="p1_t25" reading_order_no="26" segment_no="3" tag_type="text">Thus, we are able to define the luminal phenotype independ-</text>
<text top="579" left="57" width="240" height="9" font="font4" id="p1_t26" reading_order_no="27" segment_no="3" tag_type="text">ently of ER status. In contrast, our myoepithelial signature con-<a href="">[4,5,46]. </a>Genes identified in this study</text>
<text top="590" left="57" width="240" height="9" font="font4" id="p1_t27" reading_order_no="28" segment_no="3" tag_type="text">tains several members of the previously reported gene clusters</text>
<text top="602" left="57" width="240" height="9" font="font4" id="p1_t28" reading_order_no="29" segment_no="3" tag_type="text">identifying basal-like breast cancers. Some of these have been</text>
<text top="614" left="57" width="240" height="9" font="font4" id="p1_t29" reading_order_no="30" segment_no="3" tag_type="text">previously identified as myoepithelial genes in the normal</text>
<text top="626" left="57" width="240" height="9" font="font4" id="p1_t30" reading_order_no="31" segment_no="3" tag_type="text">breast epithelium, for example, TIMP3 , SPARC , JAG1 ,</text>
<text top="637" left="57" width="241" height="9" font="font5" id="p1_t31" reading_order_no="32" segment_no="3" tag_type="text">PRSS11 and CAV-1 [11], and some of them, such as</text>
<text top="649" left="57" width="240" height="9" font="font5" id="p1_t32" reading_order_no="33" segment_no="3" tag_type="text">S100A7 , SPARC and CNN1 , have previously been shown</text>
<text top="661" left="57" width="240" height="9" font="font4" id="p1_t33" reading_order_no="34" segment_no="3" tag_type="text">individually to be correlated to poor outcome [5,11,47]. Since</text>
<text top="673" left="57" width="240" height="9" font="font4" id="p1_t34" reading_order_no="35" segment_no="3" tag_type="text">our cell type specific gene signatures were derived from phe-</text>
<text top="684" left="57" width="240" height="9" font="font4" id="p1_t35" reading_order_no="36" segment_no="3" tag_type="text">notypically well characterised cell types compared to empirical</text>
<text top="696" left="57" width="240" height="9" font="font4" id="p1_t36" reading_order_no="37" segment_no="3" tag_type="text">stratification based on expression data, we were also able to<i>TIMP3</i></text>
<text top="708" left="57" width="240" height="9" font="font4" id="p1_t37" reading_order_no="38" segment_no="3" tag_type="text">identify a range of myoepithelial type genes in ER-positive</text>
<text top="720" left="57" width="240" height="9" font="font4" id="p1_t38" reading_order_no="39" segment_no="3" tag_type="text">tumours as well as those in basal-like breast cancers. Thus,<i>SPARC</i></text>
<text top="320" left="315" width="241" height="9" font="font4" id="p1_t39" reading_order_no="40" segment_no="4" tag_type="text">although the majority of the primary breast tumours within our</text>
<text top="332" left="315" width="240" height="9" font="font4" id="p1_t40" reading_order_no="41" segment_no="4" tag_type="text">malignant pool were ER-positive 'luminal' tumours, a<i>JAG1</i></text>
<text top="344" left="315" width="240" height="9" font="font4" id="p1_t41" reading_order_no="42" segment_no="4" tag_type="text">significant number of up-regulated gene sets also showed</text>
<text top="355" left="315" width="240" height="9" font="font4" id="p1_t42" reading_order_no="43" segment_no="4" tag_type="text">myoepithelial expression. The observation of myoepithelial<i>PRSS11 </i></text>
<text top="367" left="315" width="241" height="9" font="font4" id="p1_t43" reading_order_no="44" segment_no="4" tag_type="text">genes such as SFRP2 , DCN , POSTN , LUM , COL1A2 and</text>
<text top="379" left="315" width="241" height="9" font="font5" id="p1_t44" reading_order_no="45" segment_no="4" tag_type="text">COL11A1 , which showed higher expression in ER-positive<i>CAV-1 </i></text>
<text top="391" left="315" width="240" height="9" font="font4" id="p1_t45" reading_order_no="46" segment_no="4" tag_type="text">compared to ER-negative breast tumours in two other breast<a href="">[11], and some of </a>them, such as</text>
<text top="402" left="315" width="240" height="9" font="font4" id="p1_t46" reading_order_no="47" segment_no="4" tag_type="text">cancer tumour profiling studies [48,49], proved the value of<i>S100A7</i></text>
<text top="414" left="315" width="240" height="9" font="font4" id="p1_t47" reading_order_no="48" segment_no="4" tag_type="text">such an approach and demonstrated the heterogeneity of</text>
<text top="426" left="315" width="240" height="9" font="font4" id="p1_t48" reading_order_no="49" segment_no="4" tag_type="text">breast tumours with respect to the levels of luminal epithelial<i>SPARC </i></text>
<text top="438" left="315" width="240" height="9" font="font4" id="p1_t49" reading_order_no="50" segment_no="4" tag_type="text">and myoepithelial gene expression. The potential clinical sig-</text>
<text top="449" left="315" width="240" height="9" font="font4" id="p1_t50" reading_order_no="51" segment_no="4" tag_type="text">nificance of the expression of myoepithelial/basal genes in ER-<i>CNN1</i></text>
<text top="461" left="315" width="240" height="9" font="font4" id="p1_t51" reading_order_no="52" segment_no="4" tag_type="text">positive tumours has been highlighted by recent data showing</text>
<text top="473" left="315" width="240" height="9" font="font4" id="p1_t52" reading_order_no="53" segment_no="4" tag_type="text">that the promoter DNA methylation of the classic myoepithelial<a href="">[5,11,47]. </a>Since</text>
<text top="485" left="315" width="241" height="9" font="font4" id="p1_t53" reading_order_no="54" segment_no="4" tag_type="text">marker S100A2 is correlated with a poor prognosis in ER-pos-</text>
<text top="496" left="315" width="240" height="9" font="font4" id="p1_t54" reading_order_no="55" segment_no="4" tag_type="text">itive tumours [50]. In contrast, increased levels of expression</text>
<text top="508" left="315" width="241" height="9" font="font4" id="p1_t55" reading_order_no="56" segment_no="4" tag_type="text">of phosphoserine aminotransferase (encoded by PSAT1 ),</text>
<text top="520" left="315" width="240" height="9" font="font4" id="p1_t56" reading_order_no="57" segment_no="4" tag_type="text">which was another gene also identified in our myoepithelial</text>
<text top="532" left="315" width="240" height="9" font="font4" id="p1_t57" reading_order_no="58" segment_no="4" tag_type="text">transcriptome, was the strongest predictive marker for a poor</text>
<text top="543" left="315" width="240" height="9" font="font4" id="p1_t58" reading_order_no="59" segment_no="4" tag_type="text">response to tamoxifen therapy in ER-positive tumours [50].</text>
<text top="555" left="315" width="240" height="9" font="font4" id="p1_t59" reading_order_no="60" segment_no="4" tag_type="text">Our observation that the malignant epithelial expression of</text>
<text top="567" left="315" width="240" height="9" font="font4" id="p1_t60" reading_order_no="61" segment_no="4" tag_type="text">POSTN, also a myoepithelial/basal gene, is associated with</text>
<text top="579" left="315" width="241" height="9" font="font4" id="p1_t61" reading_order_no="62" segment_no="4" tag_type="text">poorer survival ( P = 0.0083) in ER-positive tumours</text>
<text top="590" left="315" width="240" height="9" font="font4" id="p1_t62" reading_order_no="63" segment_no="4" tag_type="text">demonstrates that the normal epithelial annotation of tumour</text>
<text top="602" left="315" width="240" height="9" font="font4" id="p1_t63" reading_order_no="64" segment_no="4" tag_type="text">transcripts can identify many other types of myoepithelial/<i>SFRP2</i></text>
<text top="614" left="315" width="241" height="9" font="font4" id="p1_t64" reading_order_no="65" segment_no="4" tag_type="text">basal genes, including those associated with a poor outcome.</text>
<text top="637" left="315" width="240" height="9" font="font4" id="p1_t65" reading_order_no="66" segment_no="5" tag_type="text">An important question is whether the expression of myoepithe-<i>DCN</i></text>
<text top="649" left="315" width="240" height="9" font="font4" id="p1_t66" reading_order_no="67" segment_no="5" tag_type="text">lial/basal genes in breast cancers are responsible for the prog-</text>
<text top="661" left="315" width="241" height="9" font="font4" id="p1_t67" reading_order_no="68" segment_no="5" tag_type="text">nosis and poor response to therapy or are merely surrogate<i>POSTN</i></text>
<text top="673" left="315" width="240" height="9" font="font4" id="p1_t68" reading_order_no="69" segment_no="5" tag_type="text">markers thereof. There are several lines of evidence to suggest</text>
<text top="684" left="315" width="240" height="9" font="font4" id="p1_t69" reading_order_no="70" segment_no="5" tag_type="text">that POSTN may play a role in the biology of breast cancer<i>LUM</i></text>
<text top="693" left="315" width="134" height="12" font="font4" id="p1_t70" reading_order_no="71" segment_no="5" tag_type="text">[51,52]. POSTN is a ligand of α</text>
<text top="700" left="449" width="3" height="6" font="font7" id="p1_t71" reading_order_no="72" segment_no="5" tag_type="text">v<i>COL1A2 </i></text>
<text top="693" left="451" width="5" height="11" font="font6" id="p1_t72" reading_order_no="73" segment_no="5" tag_type="text">β</text>
<text top="696" left="456" width="100" height="10" font="font4" id="p1_t73" reading_order_no="74" segment_no="5" tag_type="text">3 integrins and promotes<i>COL11A1</i></text>
<text top="708" left="315" width="240" height="9" font="font4" id="p1_t74" reading_order_no="75" segment_no="5" tag_type="text">adhesion and migration of epithelial cells [51]. Clinical studies</text>
<text top="720" left="315" width="240" height="9" font="font4" id="p1_t75" reading_order_no="76" segment_no="5" tag_type="text">of periostin expression in human cancers have demonstrated</text>
<text top="85" left="57" width="31" height="7" font="font0" id="p1_t76" reading_order_no="1" segment_no="1" tag_type="title">Figure 6<a href="">ofiling studies [48,49], proved </a>the value of</text>
<text top="286" left="57" width="265" height="7" font="font8" id="p1_t77" reading_order_no="2" segment_no="2" tag_type="text">Cumulative Kaplan-Meier curves for epithelial expression of periostin (POSTN)</text>
<text top="286" left="57" width="499" height="7" font="font2" id="p1_t78" reading_order_no="3" segment_no="2" tag_type="text">Cumulative Kaplan-Meier curves for epithelial expression of periostin (POSTN). A cohort of poor-prognosis estrogen receptor (ER)-positive tumours</text>
<text top="295" left="57" width="429" height="7" font="font2" id="p1_t79" reading_order_no="4" segment_no="2" tag_type="text">was analysed showing: (a) a significantly shorter overall survival ( P = 0.0083); (b) a shorter disease free survival ( P = 0.0136).</text>
</page>
</pdf2xml>
